Mannami T, Yoshino T, Oshima K, Takase S, Kondo E, Ohara N, Nakagawa H, Ohtsuki H, Harada M, Akagi T
Second Department of Internal Medicine, Okayama University Medical School, Okayama, Japan.
Mod Pathol. 2001 Jul;14(7):641-9. doi: 10.1038/modpathol.3880366.
Malignant lymphomas and reactive lymphoid hyperplasia (RLH) in the ocular adnexa are sometimes difficult to differentiate morphologically and have often been categorized together as a lymphoproliferative disorder. Immunogenotypic characters of these diseases have not yet been well clarified. This study included 76 cases of ocular adnexal lymphoproliferative disorders. These consisted of 52 cases of malignant lymphoma (43 primary and 9 secondary), 22 of RLH, and 2 borderline cases. There were slightly more male than female subjects. Diagnoses were based on morphology and immunophenotypic characteristics. Clonalities were detected by means of polymerase chain reaction (PCR), and immunoglobulin heavy-chain variable region (VH) genes were sequenced in 10 cases of mucosa-associated lymphoid tissue (MALT) lymphoma. MALT lymphoma constituted 86% (37 cases) of the primary lymphomas. MALT lymphomas were more indolent, more rarely disseminated, and had a lower death rate than the other primary lymphomas. Two patients exhibited coexistence of MALT and diffuse large B-cell lymphoma. The average age of patients with RLH was 5.5 years younger than that of those with MALT lymphoma. One of the cases of RLH later progressed to malignant lymphoma. B-cell clonality was detected by PCR in 57%, 55%, and 0% of primary lymphomas, MALT lymphomas and RLHs, respectively. Sequencing of VH genes revealed that the VH3 family was the most commonly expressed germline VH family (70%) and that DP-63, DP-54 and DP-47 genes were frequently found in the MALT lymphomas examined. PCR analysis was useful for differentiation between MALT lymphoma and RLH. Sequence analysis of VH genes showed that an autoimmune mechanism may be involved in the lymphomagenesis of ocular adnexal MALT lymphoma.
眼附属器的恶性淋巴瘤和反应性淋巴组织增生(RLH)有时在形态学上难以区分,并且常常被归为一类淋巴增殖性疾病。这些疾病的免疫基因型特征尚未得到很好的阐明。本研究纳入了76例眼附属器淋巴增殖性疾病。其中包括52例恶性淋巴瘤(43例原发性和9例继发性)、22例RLH以及2例临界病例。男性略多于女性。诊断基于形态学和免疫表型特征。通过聚合酶链反应(PCR)检测克隆性,并对10例黏膜相关淋巴组织(MALT)淋巴瘤的免疫球蛋白重链可变区(VH)基因进行测序。MALT淋巴瘤占原发性淋巴瘤的86%(37例)。与其他原发性淋巴瘤相比,MALT淋巴瘤进展更缓慢,更少见播散,死亡率更低。2例患者同时存在MALT淋巴瘤和弥漫性大B细胞淋巴瘤。RLH患者的平均年龄比MALT淋巴瘤患者小5.5岁。1例RLH病例后来进展为恶性淋巴瘤。PCR检测发现,原发性淋巴瘤、MALT淋巴瘤和RLH中B细胞克隆性的检出率分别为57%、55%和0%。VH基因测序显示,VH3家族是最常表达的种系VH家族(70%),并且在检测的MALT淋巴瘤中经常发现DP-63、DP-54和DP-47基因。PCR分析有助于鉴别MALT淋巴瘤和RLH。VH基因序列分析表明,自身免疫机制可能参与眼附属器MALT淋巴瘤的发生。